Skip to main content

Table 2 Effect of age and gender of healthy subjects (n = 197) on seropositivity to peptides No. 9 and No. 10

From: IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19

 

Healthy individuals (197)

Peptide

No.9

No.10

Groups

 <  = 50y

 > 50y

Female

Male

Positive

117(79.05%)

45(91.84%)

83(82.18%)

59(61.46%)

Negative

31(20.95%)

4(8.16%)

18(17.82%)

37(38.54%)

Back to article page

Virology Journal

ISSN: 1743-422X